Search Results
May 04, 2026, 07:00 ET A2Z Cust2Mate Solutions to Host First Quarter 2026 Financial Results Conference Call on Friday, May 15, 2026
https://viavid.webcasts.com/starthere.jsp?ei=1762627&tp_key=3b4649d7cdAbout A2Z Cust2Mate Solutions Corp.A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) makes in-store
More news about: A2Z Cust2Mate Solutions Corp.
May 04, 2026, 01:21 ET BlueNord Announces First Quarter 2026 Results and Proposed Cash Dividend for the Quarter
https://mb.cision.com/Public/4225/4343723/b1e763691cd3bbbc.pdfBlueNord Q1 2026 Presentation
More news about: BlueNord ASA
May 01, 2026, 09:52 ET ATRA SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026
with Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), who have received at least one prior therapy including an anti-CD20 containing regimen." Atara said that "[t]he CRL indicates that the FDA is unable to approve the EBVALLO™ BLA in its present form" because, according
More news about: Faruqi & Faruqi, LLP
May 01, 2026, 09:00 ET Diakonos Oncology Reports Positive Clinical Data from Phase 1 Pancreatic Cancer Study and Expanded Access Program in Glioblastoma at AACR and AAN 2026
dose-limiting toxicities (DLTs) observed.Increased granzyme B in CD8+ T cells and IFN-γ in CD4+ effector memory T cells, indicating enhanced cytotoxic functionality.Increased CD127 expression was observed on circulating CD8+ and CD4+ T cells post-vaccination in most patients, consistent with upregulation
More news about: Diakonos Oncology
May 01, 2026, 04:05 ET ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
conjugates (ADCs), transforming treatment for patients through our focused portfolio with ZYNLONTA® (loncastuximab tesirine-lpyl).ADC Therapeutics' CD19-directed ADC ZYNLONTA received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed
More news about: ADC Therapeutics SA
Apr 30, 2026, 19:02 ET /C O R R E C T I O N -- Amgen/
patients with newly diagnosed CD19-positive Ph-negative B-cell precursor acute lymphoblastic leukemia (B-ALL).A potentially registration-enabling Phase 2 study of subcutaneous blinatumomab has paused enrollment of both adults and adolescents with relapsed or refractory CD19-positive Philadelphia chromosome
More news about: Amgen
Apr 30, 2026, 16:05 ET PEOPLES FINANCIAL SERVICES CORP. Reports Unaudited First Quarter 2026 Earnings
interest-bearing demand deposits. As part of strategic balance sheet management initiatives, the Company continued to reduce its higher rate brokered CD portfolio. As a result, brokered time deposits decreased $40.1 million to $112.1 million at March 31, 2026 from $152.2 million at December 31, 2025.
More news about: Peoples Financial Services Corp.
Apr 30, 2026, 12:35 ET Harness Launches Cursor Plugin to Bring the Full Power of Software Delivery Into the Developer Workflow
that puts the full power of the Harness platform directly in the hands of Cursor users. With the plugin installed, developers can securely execute CI/CD pipelines, deployments, and governance workflows through natural language in the Cursor chat, all without leaving their development environment.
More news about: Harness
Apr 30, 2026, 09:07 ET ActiveState Curated Catalog Secures AI-Generated Code Across Any Development Environment
Sonatype Nexus, GitHub Packages, AWS CodeArtifact, GitLab Package Registry, Google Artifact Registry, Azure Artifacts, and others. No new tooling or CI/CD changes required.Continuous monitoring and automatic updates: When the open source community releases a fix, ActiveState builds and publishes
More news about: ActiveState
Apr 30, 2026, 09:00 ET PolyAI Selects Kong to Scale its API Infrastructure and Accelerate AI Innovation
will offer a richer developer experience, both internally and for customers adopting its APIs. These enhancements, combined with new access to deeper CI/CD integration and automation, streamline API delivery and simplify day-to-day operations.Kong Konnect also gives PolyAI the ability to track usage,
More news about: Kong Inc.
Apr 30, 2026, 07:00 ET RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
2 study of RHB-204 in CD is expected to be the first clinical study in a specifically defined MAP-positive CD patient population. There is a significant body of peer reviewed published research supporting the scientific rationale that MAP may be a root cause of CD8, however, a major hurdle
More news about: RedHill Biopharma Ltd.
Apr 29, 2026, 23:19 ET TestMu AI lança Kane CLI, nova ferramenta de automação de navegador para agentes de IA e desenvolvedores
Manager: cada caso de teste criado localmente também é salvo remotamente. Com evidências compartilháveis anexadas automaticamente.Pronto para CI/CD: executa em modo headless no GitHub Actions, GitLab CI, Jenkins e Bitbucket Pipelines. Códigos de saída padrão se integram ao fluxo de controle dos
More news about: TestMu AI (Formerly LambdaTest)
Apr 29, 2026, 23:16 ET TestMu AI lanza Kane CLI, la nueva herramienta de automatización de navegadores diseñada para agentes y desarrolladores de IA
de prueba creado localmente también se guarda de manera remota. La prueba intercambiable se puede adjuntar automáticamente.Preparada para CI/CD: se ejecuta sin procesador en GitHub Actions, GitLab CI, Jenkins y Bitbucket Pipelines. Los códigos de salida estándar se conectan al flujo de control
More news about: TestMu AI (Formerly LambdaTest)
Apr 29, 2026, 23:04 ET TestMu AI lanza Kane CLI, la nueva herramienta de automatización del navegador
Cada caso de prueba creado localmente también se guarda de forma remota. Se adjunta automáticamente una prueba compartible.Compatible con CI/CD: se ejecuta en modo sin interfaz gráfica en GitHub Actions, GitLab CI, Jenkins y Bitbucket Pipelines. Los códigos de salida estándar se integran en
More news about: TestMu AI (Formerly LambdaTest)
Apr 29, 2026, 19:51 ET TestMu AI führt Kane CLI ein, das neue Browser-Automatisierungstool für KI-Agenten und -Entwickler
Test-Manager-Synchronisation: Lokal erstellte Testfälle werden automatisch auch in der Cloud gespeichert – inklusive teilbarer Nachweise.CI/CD-fähig: Läuft headless in GitHub Actions, GitLab CI, Jenkins und Bitbucket Pipelines. Standardisierte Exit-Codes ermöglichen die direkte Integration in
More news about: TestMu AI (Formerly LambdaTest)
Apr 29, 2026, 19:49 ET TestMu AI lance Kane CLI, le nouvel outil d'automatisation du navigateur conçu pour les agents d'IA et les développeurs
test : chaque cas de test créé localement est également sauvegardé à distance. Une preuve partageable est jointe automatiquement.Prêt pour CI/CD : fonctionne sans problème dans GitHub Actions, GitLab CI, Jenkins et Bitbucket Pipelines. Les codes de sortie standard s'insèrent dans le flux de contrôle
More news about: TestMu AI (Formerly LambdaTest)
Apr 29, 2026, 12:14 ET Immune Cells Rewire Themselves to Keep Battling Tumors in Nutrient Poor Environments
Pathology and Laboratory Medicine researchers uncovered how killer T cells – called CD8+ T cells – keep fighting inside tumors, where nutrients are scarce and conditions are harsh. The team found that rather than simply powering down, T
More news about: Children's Hospital of Philadelphia
Apr 29, 2026, 07:47 ET AbbVie Reports First-Quarter 2026 Financial Results
subcutaneous (SC) induction in the treatment of adult patients with moderately to severely active Crohn's disease (CD). AbbVie expects an approval decision later this year, which would offer adult CD patients an additional option for induction of Skyrizi. The submission is supported by data from the Phase 3
More news about: AbbVie
Apr 29, 2026, 06:59 ET 테스트뮤 AI, AI 에이전트•개발자용 브라우저 자동화 도구 Kane CLI 출시
Kane CLI 테스트를 다시 Playwright로 변환할 수도 있다. 처음부터 다시 작성할 필요가 없다.내장 테스트 매니저 동기화: 로컬에서 생성된 모든 테스트 케이스는 원격에도 함께 저장된다. 공유 가능한 증거가 자동으로 첨부된다.CI/CD 지원: GitHub Actions, GitLab CI, Jenkins, Bitbucket Pipelines에서 헤드리스 모드로 실행된다. 표준 종료 코드(exit code)가 별도의 커스텀 스크립트 없이 파이프라인 제어 흐름에 바로 연동된다.컨텍스트
More news about: TestMu AI (Formerly LambdaTest)
Apr 28, 2026, 17:28 ET Pacific West Bancorp ("PWBK") Announces First Quarter 2026 Financial Results
Investments - CD-
More news about: Pacific West Bancorp
Apr 28, 2026, 12:01 ET TestMu AI Launches Kane CLI, the New Browser Automation Tool Built for AI Agents and Developers
scratch.Inbuilt Test Manager sync: Every test case created locally is also saved remotely. Shareable proof attached automatically.CI/CD ready: Runs headlessly in GitHub Actions, GitLab CI, Jenkins, and Bitbucket Pipelines. Standard exit codes plug into pipeline control flow without any
More news about: TestMu AI (Formerly LambdaTest)
Apr 28, 2026, 11:57 ET TestMu AI Launches Kane CLI, the New Browser Automation Tool Built for AI Agents and Developers
scratch.Inbuilt Test Manager sync: Every test case created locally is also saved remotely. Shareable proof attached automatically.CI/CD ready: Runs headlessly in GitHub Actions, GitLab CI, Jenkins, and Bitbucket Pipelines. Standard exit codes plug into pipeline control flow without any
More news about: TestMu AI (Formerly LambdaTest)
Apr 28, 2026, 10:54 ET Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution
with HLX07 or serplulimab injection for the treatment of advanced colorectal cancer and other solid tumors. HLX3901, a tetraspecific antibody of DLL3×DLL3×CD3×CD28, received approval for clinical trial, demonstrating significant potential in refractory solid tumors through multi-target synergistic activation
More news about: Fosun Pharma
Apr 28, 2026, 10:30 ET De Medio Oriente a América Latina: cómo Beyond ONE opera Virgin Mobile para 7 millones de clientes
https://mma.prnewswire.com/media/2967525/Beyond_One_Logo_black_7e0f41fba65117f85a3cd9a65a4a1008_Logo_Logo.jpg
More news about: Beyond ONE
Apr 28, 2026, 08:00 ET Trailhead Biosystems Expands iPSC Derived Cell Portfolio with TrailBio® Endothelial Cells
variability and supports reproducible results in research applications.TrailBio® Endothelial Cells express key endothelial markers including CD31, CD144 and von Willebrand Factor, with greater than 90% purity. These endothelial cells are functionally validated across multiple in vitro assays, including
More news about: Trailhead Biosystems Inc